Fingerprint
Dive into the research topics where Amir Mortazavi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Determinants of pancreatic tropism in metastatic renal cell carcinoma
Xu, H., Kapur, P., Christie, A., Nielsen, A. W., Perny, A., Brandenburg, O., Small, C., Miyata, J., Zhong, H., Roberts, C., Elias, R., Tcheuyap, V., Duarte, C., van Bokhoven, A., Panian, J., Li, H., Collier, K. A., Zynger, D., Meza, L. & Beuselinck, B. & 7 others, , 2026, In: JCI Insight. 11, 5, p. 1-21 21 p., e195195.Research output: Contribution to journal › Article › peer-review
Open Access -
CNPY2 in Solid Tumors: Mechanisms, Biomarker Potential, and Therapeutic Implications
Mullick Chowdhury, S., Hong, F., Rolfo, C., Li, Z., He, K., Wesolowski, R., Mortazavi, A. & Meng, L., Feb 2025, In: Biology. 14, 2, 214.Research output: Contribution to journal › Review article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches
Khorasanchi, A., Hong, F., Yang, Y., Singer, E. A., Wang, P., Li, M., Zheng, L., Monk, P., Mortazavi, A. & Meng, L., 2025, In: Cancer Drug Resistance. 8, 9.Research output: Contribution to journal › Review article › peer-review
Open Access20 Link opens in a new tab Scopus citations -
Tyrosine Kinase Inhibitors Outperform Immune Checkpoint Inhibitors in Bone-Predominant Metastatic Renal Cell Carcinoma: A Multicenter Real-World Analysis
Meng, L., Psutka, S. P., Gheeya, J., Li, M., Noonavath, M., Orcutt, D., Gross, E., Collier, K. A., Mortazavi, A., Folefac, E., Monk, P. & Yang, Y., 2025, In: Journal of Cancer. 16, 14, p. 4047-4054 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines
Patel, D. M., Mateen, R., Qaddour, N., Carrillo, A., Verschraegen, C., Yang, Y., Li, Z., Sundi, D., Mortazavi, A. & Collier, K. A., Jan 2024, In: Cancers. 16, 2, 335.Research output: Contribution to journal › Review article › peer-review
Open Access17 Link opens in a new tab Scopus citations